Cargando…
Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis
Objective This study represents the first 10 year analysis of the efficacy and toxicity of stereotactic body radiotherapy (SBRT) in the treatment of early low-risk prostate cancer. Materials and methods Two hundred and thirty males were treated with Cyberknife SBRT to a dose of 35 Gray (Gy) or 36.25...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679773/ https://www.ncbi.nlm.nih.gov/pubmed/29152425 http://dx.doi.org/10.7759/cureus.1668 |